![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 29, 22166-22171, July 21, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, March 2, 2000
In Caenorhabditis elegans, the
predicted transcription factor SKN-1 is required for embryonic
endodermal and mesodermal specification and for maintaining
differentiated intestinal cells post-embryonically. The SKN-1
DNA-binding region is related to the Cap`n'Collar (CNC) family of
basic leucine zipper proteins, but uniquely, SKN-1 binds DNA as a
monomer. CNC proteins are absent in C. elegans, however; and their involvement in the endoderm and mesoderm suggests some functional parallels to SKN-1. Using a cell culture assay, we show that
SKN-1 induces transcription and contains three potent activation
domains. The functional core of one domain is a short motif, the DIDLID
element, which is highly conserved in a subgroup of vertebrate CNC
proteins. The DIDLID element is important for SKN-1-driven
transcription, suggesting a likely significance in other CNC proteins.
SKN-1 binds to and activates transcription through the
p300/cAMP-responsive element-binding protein-binding protein (CBP)
coactivator, supporting the genetic prediction that SKN-1 recruits the
C. elegans p300/CBP ortholog, CBP-1. The DIDLID element
appears to act independently of p300/CBP, however, suggesting a
distinct conserved target. The evolutionarily preservation of the
DIDLID transcriptional element supports the model that SKN-1 and some
CNC proteins interact with analogous cofactors and may have preserved
some similar functions despite having divergent DNA-binding domains.
During development, establishment of cell fates frequently
involves conserved regulatory pathways. In the early
Caenorhabditis elegans embryo, endodermal (intestinal) fates
are specified by GATA family transcription factors (END-1, END-3,
ELT-2) that are related to those that mediate endoderm development in
Drosophila (Serpent) and vertebrates (GATA-4/5/6) (1-3).
This program is triggered by maternally expressed SKN-1, a predicted
transcription factor (4) that also specifies mesodermal lineages
(pharynx and some body wall muscle) (5). The presence of consensus
SKN-1-binding sites adjacent to the end-1 gene along with
the timing of its expression suggests that SKN-1 may activate
end-1 directly (2). SKN-1 is also required in the endoderm
post-embryonically, to prevent differentiated intestinal cells from
undergoing severe atrophy (5).
Apparent SKN-1 orthologs have not been identified outside of nematodes,
but in its DNA-binding region, SKN-1 is related to a subgroup of basic
leucine zipper transcription factors (4, 5), the
CNC1 proteins. A basic
DNA-binding region at the SKN-1 COOH terminus is particularly similar
to those of CNC proteins, but SKN-1 lacks a zipper dimerization domain
(Fig. 1, A and C)
and, uniquely, binds DNA as a monomer (4). Its DNA binding requires the
adjacent Like SKN-1, many CNC proteins are involved in the development or
function of endodermal or mesodermal cells. Drosophila
CNC is required for specification of pharyngeal segments
(10), and vertebrate p45NF-E2 is involved in hematopoiesis
(11). In mice, different knockouts of the Nrf1
(NF-E2 related
factor-1; also LCRF-1/TC11) gene either cause a
fetal liver microenvironment defect (12) or appear to block
cell-to-cell induction of the mesoderm, a function usually ascribed to
endodermal cells (13). Both NRF1 and NRF2 directly induce expression of
detoxification enzymes (14-17), a pathway that is markedly stimulated
in the liver and intestine (14). Supporting the idea that some CNC
protein functions might parallel those of SKN-1, neither they nor their
dimerization partners, the Maf basic leucine zipper proteins (18, 19),
appear to be encoded in the complete C. elegans genome (data
not shown).
Genetic evidence suggests that SKN-1 may interact functionally with
CBP-1, the C. elegans ortholog of the p300/CBP transcription coactivators. (20). p300/CBP proteins are metazoan histone
acetyltransferases that are involved in developmental and inducible
gene expression and that are recruited by numerous activators (21),
including the CNC protein p45NF-E2 (22). C. elegans CBP-1 is required for specification of all non-neuronal
embryonic developmental lineages (20). Endodermal differentiation can
be restored in embryos that lack either CBP-1 or SKN-1, however, by
inhibition of histone deacetylases (20). This suggests that in the
endoderm, SKN-1 might recruit the CBP-1 histone acetyltransferase
activity directly. It remains possible, nevertheless, that lack of
histone deacetylases simply restores expression of downstream genes
independently of possible histone acetyltransferase recruitment by
SKN-1.
We have addressed these issues by investigating how SKN-1 regulates
transcription. C. elegans cell lines have not been
developed, but given the conservation of the eukaryotic mRNA
transcription machinery (23), SKN-1 would be predicted to be active in
mammalian cells. Using transfection assays, we show here that SKN-1 is
a powerful activator of transcription that contains three
transactivation domains. The functional core of one domain consists of
a short sequence (the DIDLID element) (Fig. 1B) that is
specific to SKN-1-related proteins and to the NRF group of CNC
proteins. The p300/CBP proteins appear to be direct cofactors of SKN-1,
but not to be critical for the activity of the DIDLID element. The
conservation and transcriptional function of the DIDLID element suggest
that SKN-1 and the NRF CNC proteins share a common transcriptional
protein target in addition to p300/CBP and, during evolution, may have
maintained some parallel functions in endodermal cells.
Plasmid Constructions--
For analysis of full-length SKN-1, a
FLAG epitope was added at its NH2 terminus. A
SpeI site was first created by polymerase chain reaction,
which added a linker of LV prior to the initial methionine, and then
the FLAG epitope (DYKNDDDKDP) was added as an R1/SpeI
fragment prior to cloning into the CMV-based vector CS2 (24). To delete
the DIDLID motif ( Transfections and Analysis--
HeLa cells were used in all
transfections and maintained in Dulbecco's modified Eagle's medium
plus 10% fetal calf serum. Cells were transfected transiently by
calcium phosphate for 18 h at 3% CO2 and then placed
in 5% CO2 and harvested 24-26 h later. Transfections for
CAT assays were performed in six-well plates and brought to 10 µg of
total DNA with Bluescript. Transfections for Western blotting and
electrophoretic mobility shift assays were performed in 100-mm plates
using 20 µg of total DNA. CAT assays were performed as described
(25). An internal control was omitted because some SKN-1 constructs
influenced overall gene expression, but not transfection efficiency
(data not shown), presumably through squelching. Samples were
normalized for total protein concentration. Six independent values were
generated for each data point, of which a representative is shown in
each figure. Each fell in the linear range for CAT and represented an
average of three experiments unless otherwise indicated, with error
bars showing S.D. values. Cotransfection of a Protein Analysis--
Lysates for Western and electrophoretic
mobility shift assay analyses were prepared as described (27), and
SKN-1 was expressed by in vitro translation using Promega
kits. For Western blotting, proteins were separated on a 7.5% gel and
transferred to nitrocellulose membranes (Schleicher & Schüll),
which were probed with an anti-SKN-1 monoclonal antibody (a gift of J. Priess) and visualized by enhanced chemiluminescence (Amersham
Pharmacia Biotech). Electrophoretic mobility shift assays were carried
out as described (9) with an extract equivalent of 10% of a 100-cm
plate/lane. Binding of SKN-1 to a 32P-labeled SK1
oligonucleotide (4) was assayed and was competed either by excess
unlabeled SK1 DNA or by a mutant site (MSK1) to which SKN-1 does not
bind specifically (4). Glutathione S-transferase (GST)-p300
proteins were expressed as described (28) and then coupled to
glutathione-agarose beads (Sigma) and incubated for 2 h with
35S-labeled SKN-1 in 25 mM Hepes, 250 mM NaCl, 25 mM EDTA, 0.1% Nonidet P-40, and
protease inhibitor mixture as described (28). Beads were washed in
phosphate-buffered saline plus 0.1% Nonidet P-40 five times, and then
proteins were eluted in sample buffer and electrophoresed on an
SDS-polyacrylamide gel.
A Short Transactivation Motif Specific to SKN-1 and Some
CNC-related Basic Leucine Zipper Proteins--
When expressed by
transfection in human (HeLa) cells, SKN-1 strongly activated a
reporter containing four SKN-1-binding sites (SKN-1/TK-CAT) (Fig.
2), but not the corresponding control
reporter lacking those sites (data not shown). SKN-1/TK-CAT was not
activated by the SKN-1 DNA-binding domain alone (SKN-1-(449-533)) or
by SKN-1 residues 1-391, which encompass its similarity to a C. elegans SKN-1-related gene (SRG-1) (5) outside of the DNA-binding
domain (data not shown) (Fig. 2). When fused to the yeast Gal4
DNA-binding domain, however, residues 1-391 (Gal4-SKN-(1-391))
strongly activated a Gal4-based reporter (E1B-CAT) (Fig.
3A) (28). They did not activate a control reporter lacking Gal4 sites (data not shown), suggesting that this SKN-1 region can bind and recruit transcription complexes. Residues 1-448 similarly constituted a powerful activator that was comparable to the viral protein VP16 (Fig.
3A).
Outside of their DNA-binding domains, SKN-1, NRF1, and NRF2 are highly
related within a short NH2-terminal motif, which we refer
to as "DIDLID" after part of its sequence (Fig. 1, A and B). This motif is also present in SRG-1 and an SKN-1 homolog
in the nematode Caenorhabditis briggsae (Fig.
1B), but among CNC proteins, it appears to be restricted to
NRF1 and NRF2 orthologs (data not shown). The DIDLID element appears to
be present only in SKN-1- and CNC-related proteins, and SKN-1 and NRF1
are more closely related within it (92%) (Fig. 1, B and
C) than in their DNA-binding basic regions (86%),
suggesting that it has a specific and conserved function. The NRF2
DIDLID element is located adjacent to a domain that is lacking in SKN-1
and that can retain NRF2 in the cytoplasm, but the DIDLID element is
not involved in this interaction (29). The DIDLID element includes
alternating charged and hydrophobic residues (Fig. 1B), but
is not predicted to form an amphipathic
Supporting this idea, activation by the SKN-1 NH2 terminus
was not substantially diminished by COOH-terminal deletions to position
112 (Gal4-SKN-(1-112)), but was abrogated by further removal of the
DIDLID element (Gal4-SKN-(1-98)) (Fig. 3A). Within residues
1-112, only the 14-residue DIDLID element activated significantly on
its own, to ~10% of the level induced by SKN-1-(1-391) or VP16 (Gal4-SKN-(99-112)) (Fig. 3A), suggesting that it forms the
functional core of the SKN-1 NH2-terminal activation domain
(domain A) (Fig. 1A). Deletion of the DIDLID motif from
full-length SKN-1 ( Activation of Transcription by Other SKN-1
Regions--
Considerable transcriptional activity remained after
deletion of the DIDLID element ( Contributions of p300/CBP Proteins to SKN-1 Function--
The
model that C. elegans CBP-1 cooperates directly with SKN-1
predicts that recruitment of p300/CBP would be important for its
activation of transcription in human cells. This is particularly likely
because CBP-1 is related to p300 throughout its length, especially
within its predicted functional domains (20). Supporting this idea,
in vitro translated SKN-1 bound specifically to GST fusion
proteins that contain either the NH2- or COOH-terminal region of human p300 (Fig.
5A), each of which interacts
with numerous transcription activators (21). In contrast, SKN-1 did not
bind to the p300 center (Fig. 5A), which contains the
histone acetyltransferase domain and generally does not bind directly
to activators (21). SKN-1-dependent transcription was
increased by expression of p300 in increasing amounts (up to 7-fold)
(Fig. 5B) and was decreased by ~80% by expression of the
adenovirus E1A 12 S protein (Fig. 5C), which binds and
inhibits both p300/CBP and PCAF (21, 33-35). SKN-1-dependent transcription was also inhibited by an E1A
mutant that does not bind the retinoblastoma (Rb) protein (pM47AI24), but not by one that does not bind p300/CBP (RG2) (Fig.
5C).
These findings raise the question of whether p300/CBP proteins are
required by the DIDLID element or other SKN-1 activation domains.
Coexpression of p300 significantly enhanced the activity of either
domain B or domain C, but not that of domain A (Fig. 5D),
suggesting that p300/CBP protein levels are not limiting for function
of the core DIDLID element (Fig. 1A). Each SKN-1 activation
domain, but not VP16, was inhibited by both E1A and the E1A Rbmut
protein (Fig. 5E), which does not bind the Rb protein. None
were repressed by the E1A The presence of a DNA-binding domain in SKN-1 (4) and its
localization to nuclei (36) suggested previously that SKN-1 is likely
to regulate transcription. We have shown here that SKN-1 is a potent
activator of transcription when it binds its cognate site (Fig. 2).
SKN-1 interacts with two regions of human p300 in vitro
(Fig. 5A), and p300/CBP proteins contribute to its activity (Fig. 5, B and C). Given the extensive similarity
between p300/CBP proteins and their C. elegans ortholog
CBP-1, these data support the model that SKN-1 may recruit CBP-1
directly to promoters as a cofactor in vivo (20).
Overexpression of p300 potentiated SKN-1 activation of domains B and C
(Fig. 5D), suggesting that it can be recruited directly or
indirectly by them. Domain B was not inhibited by E1A mutants in which
binding to either p300/CBP (p300mut) or PCAF (E55) in particular was
impaired (Fig. 5E), implicating each of these histone
acetyltransferases in its activity. Domain C was partially inhibited by
these E1A mutants (Fig. 5E), however, suggesting either that
it may require both histone acetyltransferases simultaneously or
might act on an independent E1A target. The activity of domain A, which
contains the DIDLID element (Fig. 1A), was not enhanced
significantly by p300 expression (Fig. 5D), and was
inhibited by E1A p300mut (Fig. 5E), suggests that it has a target that
is distinct from p300/CBP.
The conservation of the DIDLID element across evolution (Fig. 1,
B and C) supports the model that SKN-1 and the
CNC proteins evolved from a common precursor (4). This conservation is
particularly striking because the DIDLID motif is separate from the
DNA-binding domain and was maintained despite divergences in how these
proteins bind DNA (Fig. 1C). Point mutants in the DIDLID
element dramatically decreased SKN-1-driven transcription in mammalian
cells (Fig. 4A), supporting the idea that it mediates a
highly specific interaction that is common to these proteins. In
apparent contrast to our findings, an NRF2 fragment that contained the
DIDLID element appeared to lack transcriptional activity in Gal4 fusion
assays (29). This particular NRF2 fragment also included the inhibitory
domain that can retain NRF2 in the cytoplasm (29), however, suggesting that in this context, the DIDLID element might have been masked or not
present in the nucleus.
Our findings suggest that SKN-1 and CNC proteins may have preserved
some parallel functions in the endoderm and mesoderm. Also supporting
this idea, in all of these proteins, hydrophobic residues on the CNC
region surface are conserved that are not predicted to influence
folding or DNA binding, but instead form a pocket, suggesting a common
protein-protein interaction (8). The CNC protein most analogous to
SKN-1 may be NRF1, which contains DIDLID (Fig. 1, B and
C) and appears to be involved in endodermal and mesodermal
differentiation and regulation of detoxification genes (13, 15, 16).
These similarities suggest a particularly intriguing possibility, that
the little understood requirement for SKN-1 to maintain the viability
of differentiated intestinal cells (5) might involve functions that
parallel the role of the NRF1 and NRF2 proteins in antioxidant responses.
We thank Martin Victor and Blackwell
laboratory members for critically reading the manuscript.
*
This work was supported by National Institutes of Health
Grants GM50900 (to T. K. B.), GM58012 (to Y. S.), and DK09416 (to A. K. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Center for Blood
Research, 200 Longwood Ave., Harvard Medical School, Boston, MA 02115. Tel.: 617-278-3150; Fax: 617-278-3131; E-mail: blackwell@ cbr.med.harvard.edu.
Published, JBC Papers in Press, April 6, 2000, DOI 10.1074/jbc.M001746200
The abbreviations used are:
CNC, Cap`n'Collar;
CBP, cAMP-responsive element-binding protein-binding protein;
CMV, cytomegalovirus;
TK, thymidine kinase;
CAT, chloramphenicol
acetyltransferase;
GST, glutathione S-transferase;
PCAF, p300/CBP-associated factor.
A Conserved Transcription Motif Suggesting Functional Parallels
between Caenorhabditis elegans SKN-1 and
Cap`n'Collar-related Basic Leucine Zipper Proteins*
,
,
,
,
§¶
Center for Blood Research and the
§ Department of Pathology, Harvard Medical School,
Boston, Massachusetts 02115
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical "CNC region" (Fig. 1, A and
C) (4, 6-8), which is otherwise found only in CNC proteins.
An adjacent SKN-1 element that is lacking in CNC proteins, the
NH2-terminal arm (Fig. 1, A and C),
contributes additional binding affinity and specificity (6, 9). These
similarities and differences pose the question of whether SKN-1- and
CNC-related proteins simply bind DNA through related but divergent
mechanisms or might share a closer functional relationship.

View larger version (26K):
[in a new window]
Fig. 1.
SKN-1 sequence domains. A,
full-length SKN-1 sequence domains are indicated by shaded
boxes. Separable transactivation domains (A, B, and C) are shown
below the diagram, with their major functional units demarcated by a
heavy line. B, shown is a sequence comparison of
DIDLID motifs, with SKN-1 residue numbers indicated. Conserved amino
acids are indicated by gray boxes, and nonconserved changes
by white boxes. The Gallus gallus (chicken) ECH
DIDLID element constitutes the NH2 terminus of the protein.
C, shown are similarities between SKN-1 and CNC proteins.
Black arrows indicate percent similarity (BLOSUM62 matrix)
between adjacent proteins within sequence domains that are colored as
described for A and within the leucine zipper
(yellow). Gray arrows beneath Drosophila
melanogaster CNC, which lacks a DIDLID element, show percent
similarity to SKN-1. SKN-1 is comparably similar to other CNC proteins
within the corresponding regions (not shown). Bars span the
DNA-binding domains of SKN-1 (top) and CNC proteins
(bottom). Ce, C. elegans;
Mm, Mus musculus.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
DID), an SKN-1-(113-391) fragment was generated
by polymerase chain reaction and then substituted for residues
100-391. Activation domain B was disrupted (
AD(B)) by deleting a
restriction fragment encoding residues 154-205. The double deletion
(
DID,AD(B)) was made by swapping appropriate restriction fragments.
Each deleted region was sequenced. Point mutations were constructed
with the QuickChange kit (Stratagene) and confirmed by sequencing.
Gal4-SKN-1 fusions were constructed by creating
BamHI/XbaI sites at the ends of SKN-1 sequences
using the polymerase chain reaction. These were linked to the COOH
terminus of the Gal4 DNA-binding domain within pSG424 (25), creating an
intervening linker of ISRA. Junctions were sequenced for accuracy. The
polymerase chain reaction was performed using Pfu polymerase (Stratagene). The SKN-1/TK-CAT reporter was constructed by blunting and
multimerizing the SK1 oligonucleotide (4), which corresponds to the
preferred SKN-1-binding site. A fragment with four SK1 sites in the
same orientation was then ligated into a blunted SalI site
in the TK-CAT reporter (26).
-galactosidase vector revealed that in these assays, E1A expression did not cause detectable apoptosis (data not shown).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (12K):
[in a new window]
Fig. 2.
Activation of transcription by SKN-1.
Full-length SKN-1 (0.5 µg) and the indicated mutants were assayed by
transient transfection for activation of the SKN-1/TK-CAT reporter (2.0 µg). SKN-1 sequence domains are indicated as described in the legend
to Fig. 1.

View larger version (24K):
[in a new window]
Fig. 3.
SKN-1 activation domains. A,
delineation of domain A. The SKN-1 residues shown were fused to the
Gal4 DNA-binding domain within the pSG424 vector, These Gal4-SKN-1
fusion expression constructs (100 ng) were assayed by transfection for
activation of the Gal4/E1B-CAT reporter (2 µg), which was inactive on
its own (not shown). Each experiment was standardized to the activity
of Gal4-SKN-(1-391) (100%; shown as black bars), for which
the counts/min ranged between 80,000 and 200,000. SKN-1 sequence
domains are indicated as described in the legend to Fig. 1.
B, domain B comparison of Gal4-SKN-(1-391) with the
indicated Gal4-SKN-1 fusions, assayed as described for A. C, domain C analysis of COOH-terminal Gal4-SKN-1 deletions,
performed as described for A.
-helix. It is reminiscent,
however, of short helical protein-protein interaction modules that are
involved in transcription, such as the LXXLL motif in
nuclear receptor co-activators (30, 31) and the LDFS motif in E2A
proteins (32), suggesting that the DIDLID element might also have a
transcriptional function.
DID) decreased transcription of SKN-1/TK-CAT by
60% (Fig. 4A), but did not
impair SKN-1 expression or DNA binding (Fig. 4, B and C). Transactivation by SKN-1 was comparably decreased by
mutation of its third glutamic acid to alanine (D105A), but not
arginine (D105R) (Fig. 4A), suggesting that the
hydrophilicity of this residue might be more important than its charge.
In contrast, alteration of the conserved tryptophan to either Ala
(W108A) or Arg (W108R) decreased transcription markedly (Fig.
4A), indicating that interactions involving the DIDLID
element are specific.

View larger version (35K):
[in a new window]
Fig. 4.
Analysis of activation domains in full-length
SKN-1. A, activity of SKN-1 mutants. Vectors expressing
SKN-1 or the indicated mutants (2.0 µg) were assayed for activation
of the SKN-1/TK-CAT reporter (1.0 µg) (see Fig. 2). Sequence domains
are indicated as described in the legend to Fig. 1. B, DNA
binding by SKN-1 mutants. Extracts from cells transfected with the
indicated SKN-1 derivatives were tested by electrophoretic mobility
shift assay along with in vitro translated (IVT)
SKN-1 for binding to a labeled SKN-1-binding site (4). Only bound
complexes are shown, with a nonspecific species indicated by
NS. In the indicated samples, a 500-fold excess of unlabeled
SKN-1-binding site (S) or a nonspecific sequence
(M) was added to the assay mixture. C, expression
of SKN-1 derivatives, assayed by Western blotting of the six protein
samples analyzed in B. By this assay, the DIDLID point
mutants analyzed in A were also expressed comparably to
SKN-1 (not shown).
DID) (Fig. 4A), and
analysis of internal deletions (Fig. 3B) revealed a second
SKN-1 activation domain (domain B) (Fig. 1A), which is
centered around a Glu-rich region (residues 153-183) and a predicted
amphipathic
-helix (residues 184-233). The
-helical region alone
had independent activity (SKN-1-(183-233)), which appeared to be
enhanced by the presence of the Glu-rich region (SKN-1-(153-233) and
the residues immediately NH2-terminal to it
(SKN-1-(113-233)) (Fig. 3B). Transactivation by full-length
SKN-1 was diminished by ~65% by disruption of the Glu-rich and
-helical regions (
AD(B)) and by ~90% by concurrent deletion of
the DIDLID element (
DID,AD(B)) (Fig. 4A). Neither deletion impaired SKN-1 expression or DNA binding (Fig. 4, B
and C), indicating that domain B is important for activation
of transcription by SKN-1. We investigated the remaining activity of
the
DID,AD(B) mutant (Fig. 4A) by analyzing
NH2-terminal deletions of Gal4-SKN-(1-391) (Fig.
3C). Residues 271-391 are weakly similar (20%) to
sequences near the NH2 terminus of NCoA-1 (31), a nuclear
hormone receptor coactivator that binds p300/CBP and the
p300/CBP-associated factor (PCAF), which is also a histone
acetyltransferase (21). Together, the SKN-1/NCoA-1 homology region and
downstream sequences constituted a third activation domain:
SKN-1-(233-391) (Fig. 3C) and domain C (Fig.
1A).

View larger version (30K):
[in a new window]
Fig. 5.
Involvement of p300/CBP proteins in
SKN-1-driven transcription. A, binding of p300 regions
to SKN-1. In vitro translated SKN-1 was assayed for binding
to GST or GST fusions with human p300 residues 1-596 (N),
744-1571 (M), or 1572-2370 (C) and compared
with input protein as described (28). B, effect of p300 on
full-length SKN-1 activity. Full-length SKN-1 (0.2 µg) was
cotransfected with the SKN-1/TK-CAT reporter (2 µg), the indicated
amounts of CMV p300 (28), and sufficient empty CMV expression vector to
bring the total vector amount to 1.6 µg of CMV. p300 alone did not
activate the reporter (not shown). Synergy refers to the
relative increase in SKN-1 activity (set at 1). Bars
represent the average of two data points. C, inhibition of
full-length SKN-1 by E1A. SKN-1 (250 ng) was cotransfected along with
200 ng of CMV E1A, empty CMV vector, or the indicated E1A mutants (28)
and assayed for activation of the SKN-1/TK-CAT reporter as described
for B. D, differential dependence of SKN-1
activation domains on p300/CBP. Gal4-SKN-1 domain A (residues 1-112),
Gal4-SKN-1 domain B (residues 113-233), and Gal4-SKN-1 domain C
(residues 234-391) were transfected at limiting amounts (0.005 µg)
in the presence of increasing amounts of CMV p300 and 5 µg of
Gal4/E1B-CAT reporter. The total amount of CMV expression vector was
brought to 1 6 µg. In this experiment, the activity of each SKN-1
construct was at least 5-fold lower than when 0.1 µg was transfected
(see Fig. 3) and was set at 1.0. Bars represent an average
of four data points. E, repression of SKN-1 activation
domains by E1A. 2 µg of Gal4/TK-CAT reporter were transfected along
with 0.1 µg of SKN-1 effector plasmid and 0.2 µg of Rous sarcoma
virus vector or the indicated E1A derivative. The values represent an
average of two data points. SKN-1 activation was set at 1, and the
reporter plasmid background was essentially 0. Rous sarcoma virus E1A
CR1 contains a deletion of E1A residues 40-80 (37); E1A p300mut
(TK460) lacks residues 64-68 (38); E1A E55 has Ala substitutions
across residues 56-60 (33); and E1A Rbmut (TK496) contains Ala at
positions 38-44 (37).
CR1 mutant (Fig. 5E), which
lacks conserved region 1 and does not bind either p300/CBP or PCAF. In
contrast, the SKN-1 activation domains differed in the extent to which
they were inhibited by E1A mutants that are impaired for binding to
either p300/CBP proteins (p300mut) or PCAF (E55) individually. Neither
of these last two E1A mutants repressed domain B, but each retained a
partial effect on domains A and C (Fig. 5E). They also
differed from each other in their effects on domain A, which was
repressed by ~50% by E1A p300mut (Fig. 5E), supporting
the idea that the DIDLID element targets a factor that is distinct from
p300/CBP.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Zhu, J.,
Fukushige, T.,
McGhee, J. D.,
and Rothman, J. H.
(1998)
Genes Dev.
12,
3809-3814
2.
Zhu, J.,
Hill, R. J.,
Heid, P. J.,
Fukuyama, M.,
Sugimoto, A.,
Priess, J. R.,
and Rothman, J. H.
(1997)
Genes Dev.
11,
2883-2896
3.
Fukushige, T.,
Hawkins, M. G.,
and McGhee, J. D.
(1998)
Dev. Biol.
198,
286-302
4.
Blackwell, T. K.,
Bowerman, B.,
Priess, J.,
and Weintraub, H.
(1994)
Science
266,
621-628
5.
Bowerman, B.,
Eaton, B. A.,
and Priess, J. R.
(1992)
Cell
68,
1061-1075
6.
Carroll, A. S.,
Gilbert, D. E.,
Liu, X.,
Cheung, J. W.,
Michnowicz, J. E.,
Wagner, G.,
Ellenberger, T. E.,
and Blackwell, T. K.
(1997)
Genes Dev.
11,
2227-2238
7.
Lo, M.-C.,
Ha, S.,
Pelczer, I.,
Pal, S.,
and Walker, S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
8455-8460
8.
Rupert, P. B.,
Daughdrill, G. W.,
Bowerman, B.,
and Matthews, B. W.
(1998)
Nat. Struct. Biol.
5,
484-491
9.
Kophengnavong, T.,
Carroll, A. S.,
and Blackwell, T. K.
(1999)
Mol. Cell. Biol.
19,
3039-3050
10.
Mohler, J.,
Mahaffey, J. W.,
Deutsch, E.,
and Vani, K.
(1995)
Development
121,
237-247
11.
Shivdasani, R. A.,
Rosenblatt, M. F.,
Zucker-Franklin, D.,
Jackson, C. W.,
Hunt, P.,
Saris, C. J.,
and Orkin, S. H.
(1995)
Cell
81,
695-704
12.
Chan, J. Y.,
Kwong, M.,
Lu, R.,
Chang, J.,
Wang, B.,
Yen, T. S.,
and Kan, Y. W.
(1998)
EMBO J.
17,
1779-1787
13.
Farmer, S. C.,
Sun, C. W.,
Winnier, G. E.,
Hogan, B. L.,
and Townes, T. M.
(1997)
Genes Dev.
11,
786-798
14.
Itoh, K.,
Chiba, T.,
Takahashi, S.,
Ishii, T.,
Igarashi, K.,
Katoh, Y.,
Oyake, T.,
Hayashi, N.,
Satoh, K.,
Hatayama, I.,
Yamamoto, M.,
and Nabeshima, Y.
(1997)
Biochem. Biophys. Res. Commun.
236,
313-322
15.
Venugopal, R.,
and Jaiswal, A. K.
(1998)
Oncogene
17,
3145-3156
16.
Kwong, M.,
Kan, Y. W.,
and Chan, J. Y.
(1999)
J. Biol. Chem.
274,
37491-37498
17.
Alam, J.,
Stewart, D.,
Touchard, C.,
Boinapally, S.,
Choi, A. M.,
and Cook, J. L.
(1999)
J. Biol. Chem.
274,
26071-26078
18.
Blank, V.,
and Andrews, N. C.
(1997)
Trends Biochem. Sci.
22,
437-441
19.
Motohashi, H.,
Shavit, J. A.,
Igarashi, K.,
Yamamoto, M.,
and Engel, J. D.
(1997)
Nucleic Acids Res.
25,
2953-2959
20.
Shi, Y.,
and Mello, C.
(1998)
Genes Dev.
12,
943-955
21.
Shikama, N. X.,
Lyon, J.,
and La Thangue, N. B.
(1997)
Trends Cell Biol.
7,
230-236
22.
Cheng, X.,
Reginato, M. J.,
Andrews, N. C.,
and Lazar, M. A.
(1997)
Mol. Cell. Biol.
17,
1407-1416
23.
Hampsey, M.
(1998)
Microbiol. Mol. Biol. Rev.
62,
465-503
24.
Turner, D.,
and Weintraub, H.
(1994)
Genes Dev.
8,
1434-1447
25.
Batchelder, C.,
Dunn, M. A.,
Choy, B.,
Suh, Y.,
Cassie, C.,
Shim, E. Y.,
Shin, T. H.,
Mello, C.,
Seydoux, G.,
and Blackwell, T. K.
(1999)
Genes Dev.
13,
202-212
26.
Weintraub, H.,
Davis, R.,
Lockshon, D.,
and Lassar, A.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
5623-5627
27.
Andrews, N. C.,
and Faller, D. V.
(1991)
Nucleic Acids Res.
19,
2499
28.
Lee, J. S.,
Galvin, K. M.,
See, R. H.,
Eckner, R.,
Livingston, D.,
Moran, E.,
and Shi, Y.
(1995)
Genes Dev.
9,
1188-1198
29.
Itoh, K.,
Wakabayashi, N.,
Katoh, Y.,
Ishii, T.,
Igarashi, K.,
Engel, J. D.,
and Yamamoto, M.
(1999)
Genes Dev.
13,
76-86
30.
Heery, D. M.,
Kalkhoven, E.,
Hoare, S.,
and Parker, M. G.
(1997)
Nature
397,
733-736
31.
Torchia, J.,
Rose, D. W.,
Inostroza, J.,
Kamei, Y.,
Westin, S.,
Glass, C. K.,
and Rosenfeld, M. G.
(1997)
Nature
387,
677-684
32.
Massari, M. E.,
Grant, P. A.,
Pray-Grant, M. G.,
Berger, S. L.,
Workman, J. L.,
and Murre, C.
(1999)
Mol. Cell
4,
63-73
33.
Reid, J. L.,
Bannister, A. J.,
Zegerman, P.,
Martinez-Balbas, M. A.,
and Kouzarides, T.
(1998)
EMBO J.
17,
4469-4477
34.
Chakravarti, D.,
Ogryzko, V.,
Kao, H. Y.,
Nash, A.,
Chen, H.,
Nakatani, Y.,
and Evans, R. M.
(1999)
Cell
96,
393-403
35.
Hamamori, Y.,
Sartorelli, V.,
Ogryzko, V.,
Puri, P. L.,
Wu, H. Y.,
Wang, J. Y.,
Nakatani, Y.,
and Kedes, L.
(1999)
Cell
96,
405-413
36.
Bowerman, B.,
Draper, B. W.,
Mello, C.,
and Priess, J.
(1993)
Cell
74,
443-452
37.
Trouche, D.,
and Kouzarides, T.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1439-1442
38.
Wong, H. K.,
and Ziff, E. B.
(1994)
J. Virol.
68,
4910-4920
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
From the Cover: Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction PNAS, February 19, 2008; 105(7): 2325 - 2330. |
||||
![]() |
J. H. An, K. Vranas, M. Lucke, H. Inoue, N. Hisamoto, K. Matsumoto, and T. K. Blackwell Regulation of the Caenorhabditis elegans oxidative stress defense protein SKN-1 by glycogen synthase kinase-3 PNAS, November 8, 2005; 102(45): 16275 - 16280. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Arca, F. Lombardo, J. G. Valenzuela, I. M. B. Francischetti, O. Marinotti, M. Coluzzi, and J. M. C. Ribeiro An updated catalogue of salivary gland transcripts in the adult female mosquito, Anopheles gambiae J. Exp. Biol., October 15, 2005; 208(20): 3971 - 3986. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Goszczynski and J. D. McGhee Reevaluation of the Role of the med-1 and med-2 Genes in Specifying the Caenorhabditis elegans Endoderm Genetics, October 1, 2005; 171(2): 545 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Inoue, N. Hisamoto, J. H. An, R. P. Oliveira, E. Nishida, T. K. Blackwell, and K. Matsumoto The C. elegans p38 MAPK pathway regulates nuclear localization of the transcription factor SKN-1 in oxidative stress response Genes & Dev., October 1, 2005; 19(19): 2278 - 2283. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hanover, M. E. Forsythe, P. T. Hennessey, T. M. Brodigan, D. C. Love, G. Ashwell, and M. Krause A Caenorhabditis elegans model of insulin resistance: Altered macronutrient storage and dauer formation in an OGT-1 knockout PNAS, August 9, 2005; 102(32): 11266 - 11271. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McMahon, N. Thomas, K. Itoh, M. Yamamoto, and J. D. Hayes Redox-regulated Turnover of Nrf2 Is Determined by at Least Two Separate Protein Domains, the Redox-sensitive Neh2 Degron and the Redox-insensitive Neh6 Degron J. Biol. Chem., July 23, 2004; 279(30): 31556 - 31567. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. An and T. K. Blackwell SKN-1 links C. elegans mesendodermal specification to a conserved oxidative stress response Genes & Dev., August 1, 2003; 17(15): 1882 - 1893. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |